DS18 to Showcase Industry-Leading Audio Solutions at Jeep Branson, the largest Jeep event in the Midwest

Branson, MO – June 8, 2026 – DS18, a global manufacturer of high-performance mobile audio products, will attend Jeep Branson 2026 for the first time as an event sponsor, showcasing its growing lineup of Jeep-specific audio solutions.

Held in Branson, Missouri, this event helps connect Jeepers from all over the country. Its central location, compared to SE, West Coast, or Northern events, allows for fans of the iconic vehicle to attend from anywhere in the USA. The event runs for 5 energy-packed days, June 10th-14th

“We’re excited to bring Team DS18 to the Midwest. This is our first show in the region, and we’re bringing Jeeps with full DS18 systems to showcase what we’re all about,” explains Rob Ferro, Field Marketing Manager at DS18.

DS18 is attending not only as an exhibitor, but also as an event sponsor. Ferro continues “As sponsors of the event, we’ll be bringing our vendor trailer loaded with the latest products from DS18’s Jeep lineup.”

Along with the product, Rob and his team will be bringing their own Jeeps, decked out in DS18 sound systems. This will showcase both the power and reliability of DS18 technology, as well as the earnestness with which the whole DS18 family loves Jeeps and Jeepers

Ferro commented “While we definitely feel like we have products which any Jeeper would be proud to buy and install in their vehicles, we are also here because we love these Jeeps and the people who make up this community.”

The team is also very excited for attendees to have the opportunity to experience DS18’s Jeep JL sound bars, designed for plug-and-play installation and high-output performance. They are also excited to show off their newer product lines like the NVY Tower Speakers, along with the company’s new PROJECT360 loudspeakers featuring a patent-pending rotating recone design.

But as always, the core mission for the DS18 crew goes beyond showcasing their gear or selling new speakers. It’s about building community.

“We look forward to connecting with Jeep enthusiasts across the Midwest” Ferro concludes, “and welcoming more Jeepers to Team DS18.”

This is their goal for each event, but especially this upcoming week in Branson.

For more on what DS18 will present at Jeep Branson 2026, visit their Instagram (@ds18audio) or their blog, https://ds18.com/blogs/blog/.

About DS18

DS18 is a Miami-based manufacturer of professional-grade car audio and electronics, offering a wide range of speakers, amplifiers, and audio components for vehicles. With distribution in over 89 countries, DS18 is recognized for its high-output performance, bold design, and strong presence in the global car audio community.

Media Contact
Company Name: DS18
Contact Person: Patrick Edwards
Email: Send Email
Country: United States
Website: DS18.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: DS18 to Showcase Industry-Leading Audio Solutions at Jeep Branson, the largest Jeep event in the Midwest

Membranous Nephropathy Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Roche, BeOne Medicines, Biogen, Vertex Pharma, AstraZeneca, Alexion Pharma, Climb Bio

The Key Membranous Nephropathy Companies in the market include – Roche, BeOne Medicines, Biogen, Vertex Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Climb Bio, argenx, Tenet Medicines, Mario Negri Institute for Pharmacological, Beijing Mabworks Biotech, Shanghai Jiaolian Drug R&D, Cerium Pharmaceuticals, BeiGene, Hoffmann-La Roche, Reistone Biopharma, SynAct Pharma, Alpine Immune Sciences, Walden Biosciences, Hansa Biopharma AB, and others.

 

DelveInsight’s “Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as the Membranous Nephropathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

 

Get a Free sample for the Membranous Nephropathy Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/membranous-nephropathy-market

 

Some of the key facts of the Membranous Nephropathy Market Report:

  • The Membranous Nephropathy market size is anticipated to grow with a significant CAGR during the study period (2022-2036).

  • In April 2026, Climb Bio announced that the US FDA had granted Fast Track Designation (FTD) to budoprutug for the treatment of PMN.

  • In February 2026, Roche announced that the Phase III MAJESTY study in adults with primary membranous nephropathy met its primary endpoint, showing statistically significant and clinically meaningful results with obinutuzumab.

  • Roche in its Q1 2026 presentation anticipates BLA submission for obinutuzumab in membranous nephropathy in 2026.

  • Biogen in its Q1 2026 busines update anticipates felzartamab approval in 2028-2030 in primary membranous nephropathy.

  • In November 2025, povetacicept was granted FTD by the US FDA in PMN.

  • In June 2025, Biogen announced the initiation of dosing in the global clinical study, PROMINENT. The Phase III study will evaluate the efficacy and safety of the investigational drug felzartamab compared to tacrolimus in adults diagnosed with PMN. Phase III data expected to read out in 2029.

  • In February 2025, Genentech, a subsidiary of Roche, has submitted positive Phase III data to the U.S. Food and Drug Administration (FDA) as it seeks to enter the lucrative lupus market with its CD20-targeting drug, Gazyva (obinutuzumab). Additionally, the company is investigating Gazyva for other autoimmune conditions, including systemic lupus erythematosus (SLE), childhood-onset idiopathic nephrotic syndrome, membranous nephropathy, and pediatric lupus nephritis.

  • IMNis often characterized by the antigens associated with the sub-epithelial immune complex deposits, some of them being PLA2R and THSD7A. Among the 7MM, PLA2R antigen accounted for maximum number of cases of IMN.

  • In 2025, IMN accounted for ~85% of total membranous nephropathy cases in the US, while secondary membranous nephropathy contributed to the remaining ~15%, highlighting the dominance of autoimmune origin in disease prevalence.

  • Across EU4 and the UK, nearly 20,000 IMN patients tested positive for the PLA2R antigen, while around 1,000 were associated with THSD7A, emphasizing the diagnostic importance of these target antigens in IMN.

  • Data from Japan indicates that the prevalence of IMN is expected to remain relatively consistent throughout the forecast period from 2026 to 2036, reflecting a stable epidemiological trend without significant increases or decreases in disease occurrence across the population during this timeframe.

  • Key Membranous Nephropathy Companies: Roche, BeOne Medicines, Biogen, Vertex Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Climb Bio, argenx, Tenet Medicines, Mario Negri Institute for Pharmacological, Beijing Mabworks Biotech, Shanghai Jiaolian Drug R&D, Cerium Pharmaceuticals, BeiGene, Hoffmann-La Roche, Reistone Biopharma, SynAct Pharma, Alpine Immune Sciences, Walden Biosciences, Hansa Biopharma AB, and others

  • Key Membranous Nephropathy Therapies: Obinutuzumab (GAZYVA/GAZYVARO, RG7159, GA101), Zanubrutinib (BRUKINSA), Felzartamab, Povetacicept, ALXN1920, Budoprutug, efgartigimod IV, VB119, MOR202, MIL62, B007, SNP-ACTH (1-39) Gel, Zanubrutinib, Obinutuzumab, SHR1459, AP1189, povetacicept, WAL0921, Imlifidase, and others

  • The Membranous Nephropathy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Membranous Nephropathy pipeline products will significantly revolutionize the Membranous Nephropathy market dynamics.

 

Membranous Nephropathy Overview

Membranous Nephropathy is a chronic kidney disorder where the body’s immune system attacks the membranes in the glomeruli the tiny filtering units in the kidneys. This leads to thickening of the glomerular basement membrane, causing protein to leak into the urine (proteinuria). It is a common cause of nephrotic syndrome in adults. The condition can be primary (idiopathic) or secondary to other diseases like lupus, infections, cancer, or use of certain medications. Symptoms include swelling (especially in the legs), fatigue, and foamy urine. Treatment depends on the severity and underlying cause, ranging from observation to immunosuppressive therapy.

 

To Know in detail about the Membranous Nephropathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Membranous Nephropathy Market Forecast

 

Membranous Nephropathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Membranous Nephropathy Epidemiology Segmentation:

The Membranous Nephropathy market report proffers epidemiological analysis for the study period 2022–2036 in the 7MM segmented into:

  • Membranous Nephropathy Prevalent Cases

  • Membranous Nephropathy Types-specific Prevalent Cases

  • Idiopathic Membranous Nephropathy (IMN) Prevalent Cases by Antigens

  • Membranous Nephropathy Treated Cases

 

Download the report to understand which factors are driving Membranous Nephropathy epidemiology trends @ Membranous Nephropathy Epidemiology Forecast

 

Membranous Nephropathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Membranous Nephropathy market or expected to get launched during the study period. The analysis covers Membranous Nephropathy market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Membranous Nephropathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Membranous Nephropathy Therapies and Key Companies

  • Obinutuzumab (GAZYVA/GAZYVARO, RG7159, GA101): Roche

  • Zanubrutinib (BRUKINSA): BeOne Medicines

  • Felzartamab: Biogen

  • Povetacicept: Vertex Pharmaceuticals

  • ALXN1920: AstraZeneca / Alexion Pharmaceuticals

  • Budoprutug: Climb Bio

  • GAZYVA (obinutuzumab): Hoffmann-La Roche

  • MOR202 (felzartamab): MorphoSys/HI-Bio

  • efgartigimod IV: argenx

  • VB119: Tenet Medicines

  • MOR202: Mario Negri Institute for Pharmacological

  • MIL62: Beijing Mabworks Biotech

  • B007: Shanghai Jiaolian Drug R&D

  • SNP-ACTH (1-39) Gel: Cerium Pharmaceuticals

  • Zanubrutinib: BeiGene

  • Obinutuzumab: Hoffmann-La Roche

  • SHR1459: Reistone Biopharma

  • AP1189: SynAct Pharma

  • povetacicept: Alpine Immune Sciences

  • WAL0921: Walden Biosciences

  • Imlifidase: Hansa Biopharma AB

 

Discover more about therapies set to grab major Membranous Nephropathy market share @ Membranous Nephropathy Treatment Landscape

 

Membranous Nephropathy Market Drivers

  • Increasing Diagnosis of Autoimmune Kidney Diseases: Improved awareness and diagnostic capabilities are leading to earlier detection of membranous nephropathy (MN), supporting market growth.

  • Advancements in Biomarker-Based Diagnosis: The use of biomarkers such as anti-PLA2R and anti-THSD7A antibodies has enhanced disease identification, monitoring, and treatment selection.

  • Emergence of Targeted Therapies: Development of novel immunomodulatory and B-cell-targeted therapies is expanding treatment options beyond conventional immunosuppressants.

  • Growing Research and Clinical Trial Activity: Increased investment in rare kidney disease research and a robust pipeline of emerging therapies are driving innovation in the MN market.

 

Membranous Nephropathy Market Barriers

  • Rare Disease Prevalence: The relatively low patient population limits market size and can reduce commercial incentives for therapy development.

  • High Cost of Advanced Therapies: Biologics and targeted treatments may impose significant financial burdens on patients and healthcare systems.

  • Complex Disease Heterogeneity: Variability in disease progression, response to treatment, and relapse rates can complicate clinical management and therapeutic development.

  • Limited Long-Term Clinical Data: Many emerging therapies still require extensive long-term efficacy and safety data before achieving widespread adoption.

 

Scope of the Membranous Nephropathy Market Report

  • Study Period: 2022–2036

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Membranous Nephropathy Companies: Roche, BeOne Medicines, Biogen, Vertex Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Climb Bio, argenx, Tenet Medicines, Mario Negri Institute for Pharmacological, Beijing Mabworks Biotech, Shanghai Jiaolian Drug R&D, Cerium Pharmaceuticals, BeiGene, Hoffmann-La Roche, Reistone Biopharma, SynAct Pharma, Alpine Immune Sciences, Walden Biosciences, Hansa Biopharma AB, and others

  • Key Membranous Nephropathy Therapies: Obinutuzumab (GAZYVA/GAZYVARO, RG7159, GA101), Zanubrutinib (BRUKINSA), Felzartamab, Povetacicept, ALXN1920, Budoprutug, efgartigimod IV, VB119, MOR202, MIL62, B007, SNP-ACTH (1-39) Gel, Zanubrutinib, Obinutuzumab, SHR1459, AP1189, povetacicept, WAL0921, Imlifidase, and others

  • Membranous Nephropathy Therapeutic Assessment: Membranous Nephropathy current marketed and Membranous Nephropathy emerging therapies

  • Membranous Nephropathy Market Dynamics: Membranous Nephropathy market drivers and Membranous Nephropathy market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Membranous Nephropathy Unmet Needs, KOL’s views, Analyst’s views, Membranous Nephropathy Market Access and Reimbursement

 

To know more about Membranous Nephropathy companies working in the treatment market, visit @ Membranous Nephropathy Clinical Trials and Therapeutic Assessment

 

Table of Contents

1. Membranous Nephropathy Market Report Introduction

2. Executive Summary for Membranous Nephropathy

3. SWOT analysis of Membranous Nephropathy

4. Membranous Nephropathy Patient Share (%) Overview at a Glance

5. Membranous Nephropathy Market Overview at a Glance

6. Membranous Nephropathy Disease Background and Overview

7. Membranous Nephropathy Epidemiology and Patient Population

8. Country-Specific Patient Population of Membranous Nephropathy

9. Membranous Nephropathy Current Treatment and Medical Practices

10. Membranous Nephropathy Unmet Needs

11. Membranous Nephropathy Emerging Therapies

12. Membranous Nephropathy Market Outlook

13. Country-Wise Membranous Nephropathy Market Analysis (2022–2036)

14. Membranous Nephropathy Market Access and Reimbursement of Therapies

15. Membranous Nephropathy Market Drivers

16. Membranous Nephropathy Market Barriers

17. Membranous Nephropathy Appendix

18. Membranous Nephropathy Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Membranous Nephropathy Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Roche, BeOne Medicines, Biogen, Vertex Pharma, AstraZeneca, Alexion Pharma, Climb Bio

Viltrox Launches AF 75mm F1.8 EVO & AF 90mm F2.2 Lenses

Exceptionally portable lenses with versatile everyday performance, optimized for portrait photography and video

Shenzhen, China – Jun 8th, 2026 – Viltrox today announced the launch of two new APS-C portrait prime lenses: the AF 75mm F1.8 EVO and AF 90mm F2.2 EVO. Designed for APS-C mirrorless cameras, the new lenses combine professional telephoto portrait performance with compact, lightweight construction.

Versatile For Everything, Ideal for Portraits

With the introduction of the two new EVO lenses, portrait photographers can achieve strong spatial compression and smooth, atmospheric bokeh that naturally isolates subjects from distracting backgrounds. With a minimum focusing distance of just 0.74m, these lenses also enable tighter framing and immersive close-up shots for more expressive portrait compositions.

The AF 75mm F1.8 EVO offers a versatile 112.5mm-equivalent focal length that balances strong background blur with flexible everyday usability for street photography, half-body portraits, and urban shooting. The AF 90mm F2.2 EVO provides a classic 135mm-equivalent portrait perspective with enhanced compression and subject isolation, making it particularly well suited for outdoor portraits, wedding photography, and cinematic portraiture.

Improved Image Consistency Across the Frame

Viltrox has developed new optical designs incorporating ED (Extra-low Dispersion) and HR (High Refractive Index) elements to reduce chromatic aberration and contribute to improved overall image consistency. Even at maximum aperture, the lenses deliver sharp, high-resolution image quality from center to edge, while effectively helping maintain bright, consistent illumination across the frame. This results in natural tonal transitions and refined rendering characteristics.

Both lenses are equipped with Viltrox’s STM autofocus system, delivering fast, accurate, and quiet focusing performance for both photography and video. Stable, highly responsive continuous autofocus tracking helps creators maintain focus on subjects, even in dynamic shooting environments.

Both lenses also feature a customizable Fn button, an AF/MF switch, and a switchable click/de-click aperture ring** for seamless transitions between photo and video workflows.

The Everyday Carry: Compact and Lightweight Designs

The two EVO lenses continue the series’ design language with a clean exterior, compact construction, and durable build quality. Each lens weighs under 355g*, providing a lightweight alternative to traditional telephoto portrait lenses without compromising performance. With a rubber-sealed lens mount and a smudge and water-resistant coating on the front element, they are well suited to outdoor conditions.

Pricing and Availability

For more information, please visit: https://bit.ly/4dNH8zd

Amazon Store US:

AF 75mm F1.8 EVO:https://www.amazon.com/dp/B0GR419VPM

AF 90mm F2.2 EVO:https://www.amazon.com/dp/B0GR3ZQ92S

Amazon Store Europe:

AF 75mm F1.8 EVO:https://www.amazon.de/dp/B0GR419VPM

AF 90mm F2.2 EVO:https://www.amazon.de/dp/B0GR3ZQ92S

AF 75mm F1.8 EVO (E / Z / XF) – USD $329 / GBP £319 / EUR €389

AF 90mm F2.2 EVO (E / Z / XF) – USD $369 / GBP £359 / EUR €429

*Weight may vary slightly depending on the lens mount version

** XF mount version does not include the CLICK switch, Fn button, and AF/MF switch

About Viltrox

Viltrox, established in 2009, is a globally-recognized leader in camera lenses and adapters, specializing in high-performance equipment for photography and cine. The company’s portfolio includes cinema and autofocus lenses – such as the LAB, Pro, EVO, and Air series, launched since 2018 – along with monitors, adapters, and lighting solutions.

Driven by innovation, the company expanded further into cine in 2022 with the “EPIC” anamorphic and “LUNA” zoom lenses, offering cost-effective solutions for filmmakers worldwide. Renowned for their exceptional optical quality, reliability, and accessible pricing, Viltrox products reflect a commitment to engineering excellence and user-centered design, empowering content creators in both still and motion photography.

Media Contact
Company Name: Viltrox
Contact Person: Angela Liu
Email: Send Email
Country: China
Website: https://viltrox.com/

Rockefeller’s Cleaning & Restoration Co. Marks 47 Years of Disaster Restoration in New Mexico

Rockefeller’s Cleaning & Restoration Co. Marks 47 Years of Serving New Mexico in 2026 Family-Owned, Albuquerque-Based Restoration Company Celebrates Nearly Half a Century of Helping New Mexicans Recover from Fire, Flood, and Disaster — From Georgia O’Keeffe’s Home to UNM’s Zimmerman Library

ALBUQUERQUE, N.M. – Rockefeller’s Cleaning & Restoration Co., one of New Mexico’s longest-running family-owned cleaning and disaster restoration companies, is preparing to mark its 47th year in business in 2026. What began in 1979 as a side venture to fund two University of New Mexico graduate degrees has grown into a statewide operation with a30,000-square-foot facility footprint, a fleet of more than 30 vehicles, and the largest disaster restoration equipment inventory in the state.

Founded by husband-and-wife team Larry and Kelly Borgeson, Rockefeller’s was born out of necessity and built on craft. Kelly began her undergraduate studies at Carnegie-Mellon University. Larry, a U.S. Marine Corps veteran of the Vietnam War who earned the Bronze Star, a Presidential Citation, and the Purple Heart, was working for a general contractor after returning home from his service. The two came to Albuquerque together in 1975 to complete their educations at the University of New Mexico, where Larry earned BFA and MA degrees in photography and Kelly earned BFA and MA degrees in painting and drawing. The cleaning business they started together in 1979 was meant to fund their graduate school education. Forty-seven years later, it has restored some of New Mexico’s most treasured properties.

A Portfolio That Reads Like a Tour of New Mexico History

Rockefeller’s has been called in to restore Georgia O’Keeffe’s home, the University of New Mexico’s Zimmerman Library after a major flood, the El Rey Theater in downtown Albuquerque, Romano’s Macaroni Grill following a fire, and properties damaged by the Los Alamos wildfires. The company has served as the City of Albuquerque’s emergency-services board-up provider and counts among its institutional clients the University of New Mexico, Albuquerque Public Schools, Presbyterian Healthcare Services, Kirtland Air Force Base, Sandia Casino Hotel, Inn of the Mountain Gods, the National Hispanic Cultural Center, and the Sandoval and Santa Fe County courthouses.

“Our passion is revitalizing The Land of Enchantment and helping New Mexicans get back to business,” the company says on its website — a mission that has guided every restoration project for nearly five decades.

A Second Generation Carries the Torch

The Borgeson family business is now firmly in its second generation, led by the founders’ two children, Cole and Alex Borgeson. Both have worked on and off in the family businesses their entire lives, and the two are stepping into leadership together as equal partners.Cole, the elder of the two, co-launched Rockefeller’s Construction, Inc. in 2010,expanding the company into licensed general contracting and full disaster reconstruction,and is the named license-holder on New Mexico contractor license CID #366145, valid through June 2028. Alex came on in business development in 2014, bringing prior experience from Accion New Mexico and the healthcare sector. Going forward, Cole will primarily lead the construction side of the operation and Alex will primarily lead cleaning and restoration, but the two will run both companies together.

“I feel most people think that a disaster is something that might never happen to them,but as a result there tends to be a lack of preparedness,” Alex Borgeson said in an earlier profile with Albuquerque Business First — a sentiment that captures the family’s quiet, ready-when-you-need-us approach to the work.

Built for the Worst Days

Rockefeller’s operates 24 hours a day, 365 days a year, with a one-hour statewide emergency response commitment. The company is an IICRC Certified Firm and an EPA Lead-Safe Certified Firm, and its technicians hold certifications spanning water damage restoration,applied structural drying, fire and smoke restoration, applied microbial remediation, crime and trauma scene decontamination, sewage remediation, and ozone deodorization. Few competitors in New Mexico offer the company’s full breadth of specialty services, which include fine art and document restoration, oriental rug cleaning, biohazard and trauma cleanup, methamphetamine lab remediation, CS-gas and pepper-spray decontamination, hantavirus remediation, asbestos and lead abatement, and prison and holding-cell disinfection.

The company’s vertically integrated structure — cleaning, restoration, and licensed reconstruction under one roof — sets it apart from the national franchise operators that dominate much of the Albuquerque market. When a homeowner or business owner calls Rockefeller’s after a fire or flood, the same family-owned company that boards up the structure overnight will dry it out, remediate the damage, rebuild what was lost, and coordinate directly with the insurance carrier from start to finish.

Giving Back to the Land of Enchantment

Across 47 years, Rockefeller’s philanthropic footprint has grown nearly as large as itsrestoration footprint. The company has supported more than 60 New Mexico organizations,including UNM Children’s Hospital — where the Borgesons are founding members of the Circle of Dreams donor society — UNM’s Tamarind Institute, where the family funded the main entrance of the new building at Central and Stanford SE, the Albuquerque Museum, the National Hispanic Cultural Center, the Albuquerque Youth Symphony, KNME public television, Ronald McDonald House, the Salvation Army, Casa Esperanza, the Animal Humane Association, March of Dimes, the Boys & Girls Clubs of Albuquerque and Rio Rancho, ACCION New Mexico, Big Brothers Big Sisters, and dozens of local schools from Bandelier Elementary to Albuquerque High School.

For many years, Rockefeller’s donated roughly 190 Thanksgiving turkeys annually to the Salvation Army, Ronald McDonald House, the Aquinas Newman Center, and Casa Esperanza. The company has also donated thousands of dollars in HEPA air-duct cleaning services to Ronald McDonald House and Sandia Preparatory School, and contributed library books, computer software, and equipment to Albuquerque High School — along with sponsorship of the school’s Senior Lock-up graduation event, designed to keep graduating seniors safe on graduation night.

“We donate because it allows us to strengthen, even in a small way, the circle of support for each child during this critical time,” said co-founder Kelly Borgeson, in a UNM College of Fine Arts donor profile.

Looking Ahead to Year 47 and Beyond

As Rockefeller’s enters its 47th year, the company continues to invest in equipment,training, and the next generation of New Mexico restoration professionals. With the second generation now actively leading day-to-day operations and a backlog of work that spans residential homeowners recovering from summer storm flooding to institutional clients planning long-term disaster response strategies, the Borgeson family says the next chapter is about deepening the company’s roots in the state it has called home since 1975.

For homeowners, businesses, property managers, and insurance professionals across New Mexico, the message after 47 years remains the same: when disaster strikes, Rockefeller’s will be there — by your side from start to finish.

About Rockefeller’s Cleaning & Restoration Co.

Founded in 1979 in Albuquerque, New Mexico, Rockefeller’s Cleaning & Restoration Co. and its sister company Rockefeller’s Construction, Inc. are family-owned and locally operated.The company provides 24/7 statewide emergency response for fire, water, mold, storm, biohazard, and trauma damage, along with comprehensive cleaning, restoration, and reconstruction services for residential, commercial, institutional, and government clients.Rockefeller’s holds an A+ rating with the Better Business Bureau, is an IICRC Certified Firm and EPA Lead-Safe Certified Firm, and operates the largest disaster restoration equipment inventory in New Mexico.

For more information, visit www.rockefellerscleaning.com or call(505) 268-5585.

Media Contact
Company Name: Rockefeller’s Cleaning & Restoration Co.
Contact Person: Media Relations
Email: Send Email
Address:5514 Coal Ave SE
City: Albuquerque
State: NM 87108
Country: United States
Website: https://www.rockefellerscleaning.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rockefeller’s Cleaning & Restoration Co. Marks 47 Years of Disaster Restoration in New Mexico

Woodstock Launches Woodstock MCP, a No-Code Service Connecting AI Assistants and Brokerage Accounts in Japan’s Securities Industry

Woodstock MCP enables users to connect an AI assistant to a Woodstock account and conduct activities ranging from market research to order placement through conversation, without programming.

Woodstock K.K., the company behind Woodstock, a Japanese investing app for US stocks, today launched Woodstock MCP, a service that connects an AI assistant to a brokerage account without coding. The service uses MCP, the Model Context Protocol, for this purpose without requiring programming.

Previously, linking an AI to a brokerage account for analysis or trading required building APIs and writing code, presenting a technical barrier for many investors. Woodstock MCP is designed to reduce that barrier, as setup and ongoing use do not require code.

By connecting a user’s AI assistant to their Woodstock account, the service brings market research, portfolio management, and order placement into a single conversational interface. Woodstock states that the service is intended to lower the barrier to investing through AI-assisted support.

Woodstock MCP Overview

MCP, the Model Context Protocol, is a technical standard for connecting AI assistants to external tools and data, introduced in late 2024.

Woodstock MCP builds on this standard. By linking an AI assistant to a user’s Woodstock account, it allows AI-performed analysis, drawing on external data and current news, to function as a personal investing tool. No programming knowledge is required at any stage, and users interact with their chosen AI in everyday language.

Investing Workflow Support

Woodstock MCP is designed to consolidate the investing workflow. Four stages that investors previously handled across separate tools — gathering information, analyzing it, reaching a decision, and placing an order — can be conducted within a single AI chat interface.

Woodstock MCP Features

The service supports the following functions:

  • Retrieving current figures for share prices, P/E ratios, market capitalization, and related metrics
  • Retrieving and summarizing financial statements (profit and loss, balance sheet)
  • Aggregating price changes and historical price movement for US stocks
  • Conducting analysis across market, technical, and fundamental views
  • Calculating limit order levels, such as resistance and support lines
  • Analyzing portfolio risk and preparing rebalancing proposals
  • Placing buy and sell orders in natural language, including split orders


Account Connection Process

To use Woodstock MCP, a user first applies to open an account in the Woodstock app. Once the account is open, the user connects to Woodstock MCP from their AI assistant and completes authentication.

Configuring MCP does not require code. After connection, the user interacts with the AI in everyday language. Woodstock MCP is available on desktop, mobile, and tablet.

Roadmap

Woodstock plans to develop a knowledge base of AI prompts spanning research, trading, and rebalancing. The company intends to share this material to support investment decision-making across its user base.

Availability

The Woodstock app is available for iOS and Android.

Company Overview

  • Company: Woodstock K.K.
  • Representative: Brian Yun
  • Founded: March 3, 2021
  • Website: woodstock.co
  • Financial Instruments Intermediary Service Provider: registered with the Director-General of the Kanto Local Finance Bureau, Registration No. 965
  • Affiliated Financial Instruments Business Operator: AlpacaJapan Co., Ltd.
  • AlpacaJapan registration: Financial Instruments Business Operator registered with the Director-General of the Kanto Local Finance Bureau, Registration No. 3024
  • Member associations: Japan Securities Dealers Association; Investment Management Association of Japan

Disclaimer

Before trading US stocks or other financial instruments, please read carefully the documents to be delivered prior to concluding a contract and other related materials.

When buying or selling US stocks and similar products, losses may arise as prices change in response to movements in stock markets, interest rates, and exchange rates, and to changes in the business or financial condition of issuers.

The final investment decision rests with each customer and should be made at the customer’s own judgment and responsibility.

Use of this service requires opening an account with the affiliated financial instruments business operator.

Use of Woodstock MCP requires agreement to Woodstock’s Special Provisions Concerning MCP Agent Trading.

Media Contact
Company Name: Woodstock K.K.
Contact Person: Brian Yun
Email: Send Email
Phone: +81 90 8518-1298
Address:Azabujuban, 2 Chome 20-7
State: Minato-ku, Tokyo-to
Country: Japan
Website: https://woodstock.co

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Woodstock Launches Woodstock MCP, a No-Code Service Connecting AI Assistants and Brokerage Accounts in Japan’s Securities Industry

The Boulder Group Arranges Sale of Net Leased Wendy’s Restaurant in Kalamazoo, Michigan

The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased Wendy’s restaurant located at 5455 West Main Street in Kalamazoo, Michigan for $1,600,000.

The Wendy’s property at 5455 West Main Street is situated along one of the primary retail corridors in Kalamazoo, Michigan, within Oshtemo Township. West Main Street carries approximately 29,537 vehicles per day at the intersection of Main Street and Maple Hill Drive. The property is positioned directly off the US-131 exit, providing convenient access to Interstate 94 and regional connectivity throughout southwest Michigan. The Wendy’s restaurant is surrounded by a dense concentration of national retailers and restaurants including Target, Walmart, Meijer, Kohl’s, Walgreens, Burlington, Hobby Lobby, Marshalls, PetSmart, ULTA Beauty, Five Below, Dollar Tree, Old Navy, GameStop, Dunham’s Sports, Office Depot, ALDI, Applebee’s, McDonald’s, Starbucks, Chipotle Mexican Grill, Burger King, Panera Bread, and Taco Bell. Within a 3-mile radius of the Wendy’s in Kalamazoo, the population exceeds 54,000 residents. The average household income within one mile is approximately $94,722. The median household income within three miles is approximately $55,085. The median home value within one mile is approximately $330,043. The Kalamazoo, Michigan market is home to Western Michigan University, one of the largest employers in the region. The property benefits from proximity to both US-131 and I-94, two of the most heavily traveled highways in southwest Michigan. The daytime population within three miles of the property exceeds 48,000 people, reflecting the strength of the surrounding commercial corridor.

Randy Blankstein, Jimmy Goodman and John Feeney of The Boulder Group represented the buyer in the transaction, a real estate investment group. The seller was an individual investor.

The Wendy’s at 5455 West Main Street in Kalamazoo, Michigan is leased on an absolute net basis with zero landlord responsibilities. The original lease term is 20 years with approximately 11 years remaining. The absolute net lease structure requires the tenant to pay all property taxes, insurance, and maintenance costs, providing the investor with a completely passive income stream.

The Wendy’s restaurant at 5455 West Main Street in Kalamazoo is operated by a leading restaurant company headquartered in Grand Rapids, Michigan. Meritage Hospitality Group was founded in 1986 and has grown into one of the largest Wendy’s franchise operators in the United States, managing more than 375 Wendy’s locations across 15 states. The company employs over 11,000 people and generated gross revenue of approximately $617,700,000 in 2024. The Wendy’s brand is the second-largest quick-service hamburger restaurant chain in the world, with over $12,500,000,000 in annual United States systemwide sales. The building at 5455 West Main Street was constructed in 2016 and comprises 2,600 square feet on 0.83 acres with 24 parking spaces.

“Net leased quick-service restaurant properties with long-term leases and absolute net structures continue to attract strong investor demand across all markets,” said Randy Blankstein, President of The Boulder Group. “Wendy’s remains one of the most actively traded tenants in the net lease sector due to the brand’s national recognition and proven operating performance.” Jimmy Goodman, Partner of The Boulder Group, added, “This Wendy’s property in Kalamazoo benefited from its location along a high-traffic retail corridor with over 29,500 vehicles per day and immediate proximity to the US-131 interchange, which generated significant buyer interest throughout the marketing process.” John Feeney, Senior Vice President of The Boulder Group, noted, “The buyer was attracted to the absolute net lease structure with zero landlord responsibilities and the approximately 11 years of remaining lease term, which provides a secure and passive income stream well-suited for a real estate investment fund seeking stable cash flow.”

About The Boulder Group

The Boulder Group is a boutique investment real estate service firm specializing in single tenant net lease properties. The firm provides a full range of brokerage, advisory, and financing services nationwide to a substantial and diversified client base, which includes high net worth individuals, developers, REITs, partnerships and institutional investment funds. Founded in 1997, the firm has arranged the acquisition and disposition of over $11 billion of single tenant net lease real estate transactions. From 2013–2025, the firm was ranked in the top 10 companies in the nation for single tenant retail transactions by both CoStar and MSCI Real Capital Analytics. The Boulder Group is headquartered in suburban Chicago and has an office in Denver.

More info: www.bouldergroup.com

Media Contact
Company Name: The Boulder Group
Contact Person: Randy Blankstein
Email: Send Email
Phone: 8478816388
Address:3520 Lake Avenue Suite 203
City: Wilmette
State: Illinois
Country: United States
Website: https://www.bouldergroup.com/NNN-Properties-For-Sale.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Boulder Group Arranges Sale of Net Leased Wendy’s Restaurant in Kalamazoo, Michigan

Mobilo Featured as Enterprise Category Leader in Expert Buyer’s Guide to Best Digital Business Cards for 2026

Independent buyer’s guide evaluates the digital business card category across CRM integration, bidirectional contact exchange, multi-channel communication tracking, brand control, HRIS provisioning, and event mode capabilities. Mobilo emerges as the enterprise-ready platform built to solve the 90 percent CRM problem at its source, trusted by Google, Tesla, Target, NVIDIA, and Saudi Aramco.

NEW YORK, NY – June 5, 2026 – Mobilo (mobilocard.com) is thrilled to announce its featured position as the platform leading the enterprise digital business card category in an independent expert buyer’s guide to the best digital business cards for 2026. The comprehensive analysis evaluated platforms across the criteria that define enterprise-grade networking infrastructure: automatic CRM integration, bidirectional contact exchange, multi-channel communication tracking, brand lockdown features, HRIS integration for automated provisioning, and event mode capabilities for conferences and trade shows.

The expert buyer’s guide identifies Mobilo as the platform that solves the foundational workflow problem in modern networking. Research conducted across more than 4,000 sales representatives revealed that roughly 90 percent of new contacts collected at networking events, conferences, and meetings never make it into a CRM. They sit in inbox threads, photo libraries, jacket pockets, and stacks of paper cards on desks. Mobilo was engineered from the ground up to eliminate the workflow friction that causes those contacts to be lost.

“What sets the platform apart is that it was built from the ground up to solve the 90-percent CRM problem at its source,” states the expert analysis. “The moment a card is tapped against another phone, the contact information flows automatically into the user’s CRM. There is no manual entry, no photographing of paper cards, no copy-paste from a confirmation email.”

Trusted by Google, Tesla, Target, NVIDIA, and Saudi Aramco, with over 55,000 companies actively using the platform, more than 10 million people connected, and activation across 200+ countries, Mobilo has proven enterprise readiness across technology, retail, automotive, energy, and professional services.

Mobilo delivers the comprehensive enterprise capabilities that experts identified as essential for 2026 corporate networking:

Automatic CRM Integration at the Source

  • Contact information flows automatically into the user’s CRM the moment a card is tapped
  • Native integrations with Salesforce, HubSpot, Pipedrive, and Microsoft Dynamics
  • Webhook support for custom CRM flows and proprietary systems
  • Mapped fields, lead source tags, and assignment rules built in
  • Automation pushes new leads to over 6,000 connected apps via Zapier
  • Real-time sync ensuring CRM data is always current
  • Company-wide, per-account, or team-level integration controls

Bidirectional Contact Exchange

  • Card tap automatically prompts the other person to send their information back via text message
  • Both sides walk away with a logged, enriched contact record within seconds
  • Two-way exchange flows directly into the CRM
  • Contact records created from the recipient’s own input, ensuring data accuracy
  • Clean, dated, two-way records generated automatically from each interaction
  • High data hygiene supported by recipient-entered information
  • Every interaction produces a complete record on both sides

No App Required Recipient Experience

  • Sharing works through NFC tap, QR code, or Apple NameDrop without app downloads
  • Natively supported on any iPhone or Android device manufactured from 2018 onward
  • Recipients tap, see the contact card appear, and choose to save in under five seconds
  • Feels as natural as handing over a paper card
  • All iPhones XR and newer plus 90 percent of Android devices support NFC out of the box
  • QR code fallback works with any phone camera for older devices
  • Friction-free recipient experience drives mainstream adoption

Lead Enrichment and ICP Scoring

  • Captured contacts enriched automatically with title, company name, company size, and LinkedIn profile
  • ICP Builder constructs the ideal customer profile based on company input
  • Mobilo AI scores leads against the ICP automatically
  • Prioritized follow-up surfaces the highest-value contacts first
  • Enriched context delivered immediately rather than requiring post-event research
  • Sales teams focus time on most promising opportunities by default

Three Intelligent Card Modes

  • Personal landing page mode for sharing a branded profile that looks great on any phone
  • Lead gen mode for capturing the prospect’s information before sharing your own
  • Business card mode for the fastest, most secure contact share
  • All modes use the same physical card and software backend
  • Mode selection adapts to the networking context
  • Single card delivers branded marketing presence, capture workflow, and quick exchange

Centralized Multi-Channel Follow-Up Hub

  • SMS, WhatsApp, and email follow-up tracked from a single dashboard
  • Every message logged against the contact record
  • Every reply captured alongside the original capture event
  • Full conversation history lives with the lead
  • Managers gain genuine visibility into how leads are being worked
  • Streamlines follow-up workflows by keeping every channel in one place

Tiered Card Formats for Every Budget and Brand

  • Free digital wallet card living entirely on the phone with no physical hardware required
  • Custom Classic Card from PET plastic, recyclable up to eight times
  • Wood Smart Card laser-engraved on responsibly sourced Birch or Sapele
  • Premium Metal Smart Card from stainless steel for a premium first impression
  • All formats tap the same way, sync to the same dashboard, and offer the same automation
  • Mobilo plants a tree for every wood card sold
  • Tiered approach supports mixed needs within a single organization

Enterprise Brand Control and Governance

  • Marketing and operations teams lock specific profile fields
  • Brand rules enforced across all employee cards from a central dashboard
  • Card reassignment when employees change roles
  • Single dashboard change updates every employee card when the company rebrands
  • Departed employee cards reassigned or deactivated remotely
  • Role-based permissions, audit logs, and granular access controls
  • Brand consistency maintained at scale across global teams

HRIS Sync and Automated Provisioning

  • Daily sync with HR information systems for automated card lifecycle management
  • New hires get cards created automatically when added to the HR directory
  • Title changes update employee cards the next day
  • Departing employees get cards automatically deactivated
  • No IT tickets required for routine lifecycle events
  • Eliminates manual provisioning burden for organizations with thousands of employees
  • SAML SSO integration with the company’s preferred identity provider

Event Mode for Conferences and Trade Shows

  • Preprogrammed cards distributed as part of attendee registration packages
  • Real-time data-driven view of who connected with whom across the event
  • Measure attendee engagement and quantify networking value delivered
  • Identify the most active networkers and provide leaderboard data
  • Embed event schedules, speaker information, and promotional content directly on cards
  • Transforms conference experience into measurable ROI networking layer
  • Up to 10x more leads captured from events through automated workflows

Enterprise Security and Compliance

  • SOC 2 Type II controls verified through independent attestation
  • GDPR alignment with comprehensive data handling documentation
  • Secure hosting on Google Cloud with regional residency options
  • Captured contacts encrypted in transit and at rest
  • Configurable retention windows for compliance reporting
  • Clear data map showing which fields sync to the CRM and where copies are stored
  • Audit artifacts and security pack available for procurement and legal review

Business Card Scanner for Paper Card Migration

  • Scan paper business cards received at events using Mobilo AI
  • Data enrichment automatically sends scanned paper-card contacts to the marketing database
  • Bridge legacy paper-card stacks into the digital workflow
  • Smooth transition path for organizations migrating from paper

Sustainability Built In

  • PET plastic cards recyclable up to eight times for long-term use
  • Wood cards made from responsibly sourced Birch or Sapele
  • Stainless steel metal cards fully recyclable
  • Mobilo plants a tree for every wood card sold
  • Average company saves significant printing costs by switching from paper
  • Concrete environmental impact tracking through the savings calculator

The expert buyer’s guide emphasizes Mobilo’s positioning as the enterprise category leader. According to the analysis, “the differences become more meaningful at the team and enterprise level, where CRM integration, brand control, and provisioning capabilities” define enterprise-grade platforms. The guide recommends that buyers evaluating options ask vendors specifically about CRM sync, bidirectional contact capture, communication tracking, brand lockdown features, HRIS integration, and event mode capabilities. “Platforms that handle all of these in one system, like Mobilo, tend to deliver dramatically better return on investment,” states the review.

The analysis reframes the entire category for 2026 buyers. “The best digital business cards in 2026 are not really business cards at all,” states the review. “They are networking and lead capture platforms that use a card as their physical interface. The card is just the entry point. What matters is what happens after the tap: the automatic CRM entry, the bidirectional contact exchange, the conversation tracking, the brand control, the automated provisioning, and the analytics that turn networking into measurable business activity.”

Customer adoption across global brands validates the expert conclusions. Mobilo’s customer list spans Google, Tesla, Target, NVIDIA, and Saudi Aramco, with broader adoption across more than 55,000 companies in 200+ countries. The mix across technology, retail, automotive, energy, and consulting industries reflects an enterprise-ready procurement profile: strict security requirements, integration depth, brand governance, and operational reliability.

Real-world deployment demonstrates platform impact. Customers describe Mobilo as transforming networking from an unmeasurable activity into a data-generating business function with clear ROI. Sales teams report up to 10x more event leads captured through automated workflows, with automatic enrichment and CRM sync compressing follow-up time from hours of manual entry to seconds of automated capture. Event organizers gain real-time visibility into networking engagement.

With digital business cards shifting from novelty consumer accessory to enterprise networking infrastructure in 2026, Mobilo represents the category-defining platform purpose-built for the realities of global organizations. The platform combines automatic CRM integration, bidirectional capture, brand governance, HRIS sync, event analytics, and enterprise security in a single integrated system engineered specifically for teams that take networking ROI seriously.

About Mobilo

Mobilo (mobilocard.com) is the enterprise category leader in the digital business card industry, featured in independent expert buyer’s guides for 2026 and trusted by Google, Tesla, Target, NVIDIA, Saudi Aramco, and over 55,000 companies across 200+ countries. The platform combines NFC and QR code physical cards in classic plastic, laser-engraved wood, and premium stainless steel formats with a comprehensive software stack including automatic CRM integration, bidirectional contact exchange, multi-channel follow-up tracking, ICP-based lead scoring, brand lockdown, HRIS sync, SSO, and event mode for conferences and trade shows. Native integrations with Salesforce, HubSpot, Pipedrive, and Microsoft Dynamics, plus 6,000+ app connections via Zapier, eliminate the workflow friction that causes 90 percent of new contacts to never reach a CRM. With SOC 2 Type II certification, GDPR alignment, Google Cloud hosting with regional residency options, and 30-day pilot deployments supporting 25 to 100 users, Mobilo is the digital business card platform for enterprises serious about networking ROI. Mobilo is headquartered in New York with offices in Amsterdam and Perth, has connected over 10 million people, and plants a tree for every wood card sold. Learn more at mobilocard.com.

Media Contact
Company Name: Mobilo
Contact Person: Pieter Limburg
Email: Send Email
Country: United States
Website: https://www.mobilocard.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Mobilo Featured as Enterprise Category Leader in Expert Buyer’s Guide to Best Digital Business Cards for 2026

24,800,000 Shares of Stock Cancellation Back to Company Treasury for Expanding Specialty Automotive Dealer with a Strategy to Scale to $200 Million in Annual Sales: Newport Gold Inc. $NWPG

24,800,000 Shares of Stock Cancellation Back to Company Treasury for Expanding Specialty Automotive Dealer with a Strategy to Scale to $200 Million in Annual Sales: Newport Gold Inc. $NWPG
$NWPG has a 24 Month Strategic Plan Including Uplisting to a Major National Exchange
  • Diversified Company Focused on High Growth Opportunities in the Automotive, Data and Digital Technology Sectors.
  • Completed Merger with NFI Empire Group of Companies, a Profitable and Rapidly Scaling Automotive Business.
  • NFI Empire Generates Over $10 Million Annual Revenue with a Strategy to Scale Beyond $200 Million via Digital Expansion in Varied Automotive Markets.
  • The Global Specialty Automotive Sector is Valued Well Over $100 Billion and is Rapidly Expanding.
  • Cancellation of up to 24,800,000 Shares of NWPG Common Stock to Strengthen Shareholder Value and Eliminate Dilution Overhang.
  • 61,000 Sq. Ft. Automotive Campus Fueling 24-Month Expansion Strategy.
  • Three Adjacent Facilities Across 20+ Acres Provide Space and Infrastructure to Scale Sales, Production, Digital Operations and Technical Development.
  • Disrupting Legacy Sales Models with a Superior, Stage One Hybrid Approach.
  • Plans to Accelerate Digital Revenue Growth, Utilize AI at “Buyer, Seller, Operator” levels, Expand Margins and Strengthen Operational Efficiency.
  • Company Objectives Include Uplisting to a Major National Exchange.
  • Proprietary Reality-Show Platform for High-Engagement Content with a Demand-Generation and Conversion Engine.

Newport Gold Inc. (Stock Symbol: NWPG) has evolved from its origins in mineral exploration into a diversified company focused on high growth opportunities in the automotive, data, and digital technology sectors. Leveraging its history of identifying and acquiring valuable assets, NWPG now seeks innovative businesses and technologies capable of delivering scalable growth and strong returns. With a mission to “mine” global opportunities in the digital landscape, NWPG aims to drive sustainable value through strategic acquisitions and investments.

NWPG hasannounced a completed a merger with NFI Empire Group of Companies (“NFI Empire”), a profitable and rapidly scaling automotive business. NFI Empire generates more than $10 million in annual revenue and operates with a clearly defined strategy to scale beyond $200 million through digital expansion across the specialty, classic, and exotic automotive markets.

After evaluating numerous public entities, NFI Empire ultimately selected NWPG based on its long corporate history and exceptionally clean capital structure; a rarity in the micro‑cap public markets. Likewise, NWPG was impressed by NFI Empire’s seasoned team of experts and strategic plans for the future. This new structure will provide a strong foundation for institutional‑grade growth, capital formation, and long‑term shareholder value.

Cancellation of Common Stock to Strengthen Shareholder Value and Eliminate Dilution Overhang

On June 4th NWPG announced that it is in final processing of the cancellation of a significant block of Common Stock to be returned to treasury.

NWPG has finalized a previous agreement with the stockholder who is now undertaking the necessary steps for the final cancellation process of up to 24,800,000 shares of NWPG Common Stock of the Company back to treasury. This action underscores management’s commitment to the long-term interests of NWPG public shareholders and reflects their confidence in the Company’s strategic direction.

Highlights and Benefits of Share Cancellation

Reduced Float: The permanent retirement of up to 24,800,000 NWPG shares directly reduces the total number of shares issued and outstanding, increasing each remaining shareholder’s proportional ownership in the Company.

Enhanced Per-Share Metrics: With fewer shares in circulation, key per-share measures, including net asset value per share and any future earnings per share, are positively impacted, reflecting the full value of NWPG assets across a smaller share base.

Founder Alignment with Shareholders: The voluntary surrender and cancellation of these shares by insiders, without compensation, demonstrates a clear alignment of interest between the founding team and the NWPG public investor base.

Elimination of Dilution Overhang: The permanent removal of this share block eliminates potential dilution risk associated with insider holdings, providing greater transparency and confidence to current and prospective investors evaluating the NWPG capital structure.

Signal of Long-Term Confidence: In the OTC, voluntary insider share cancellations are a rare and meaningful gesture. This action reflects the founders’ belief that the NWPG underlying asset value and potential are best realized by concentrating ownership among committed long-term stakeholders.

61,000 Sq. Ft. Automotive Campus Fueling 24-Month Expansion Strategy

On June 2nd NWPG announcedit completed a three-facility campus expansion that brings its total industrial footprint to more than 61,000 square feet across 20+ acres of commercial property in North East, Pennsylvania. The unified NFI Empire Campus positions NWPG to execute a focused 24-month brick-and-mortar growth strategy while scaling its digital and technical operations in parallel.

The NWPG NFI Empire Campus now comprises three adjacent, purpose-built automotive facilities:

The Clubhouse – 5,000 sq. ft. on 2 acres – serves as the NWPG original North East anchor, where NFI established its foundation in sales and high-performance custom builds after relocating from its founding location in downtown Erie, PA.

Custom Build & Services Facility – 25,000 sq. ft. on 15 acres – functions as the NWPG NFI operational nerve center, housing its full-service custom builds and vehicle restoration teams.

Sales & Technical Development Facility – 31,000 sq. ft. on 4 acres – the newest addition, secured via an option-to-purchase agreement executed April 27, 2026. This facility will house the NFI growing marketing, digital, and technical development teams as NWPG accelerates its online and digital product initiatives.

Beyond providing immediate production capacity, the consolidated campus secures the land and facilities required to support the NWPG NFI broader digital strategy – including the design, development, and launch of new digital products and platforms. The three-facility footprint is designed to accommodate both near-term sales and manufacturing scale-up and the long-term infrastructure demands of an automotive company operating across physical and digital channels.

2026 Letter to Shareholders Highlighting Growth, Strategy and Future Outlook

On April 29th NWPG released its 2026 Letter to Shareholders, offering a comprehensive look at the company’s performance, strategic progress, and priorities for the year ahead. In the message, NWPG leadership reflects on key milestones and outlines the initiatives shaping the next phase of growth. Included in the NWPG letter was the following commentary:

NWPG is positioning its recent merger company NFI Empire for rapid expansion and long-term value creation within the multi-billion-dollar global specialty automotive markets.

A Market Poised for Digital Transformation

The global specialty automotive sector, valued well over $100 billion (Collectible cars: From niche market to growth and innovation engine | McKinsey), continues to experience strong demand for high‑value vehicles, offered on a variety of platforms, both physical and digital. Yet despite this size, much of the industry still relies on outdated legacy processes that limit efficiency, reach, transparency, and customer experience. This gap presents a compelling opportunity for innovation, modernization, and scalable disruption.

NWPG and NFI Empire enter this market with a proven, profitable, asset‑light operating model. NFI Empire closed 2025 with gross revenue of $10.3M, continued heavy investment in key people, systems, equipment and the development of a proprietary “white glove” auction platform, while still generating a net profit. A continually developing, vertically integrated platform blends physical infrastructure with digital capabilities, enabling efficient scaling without heavy capital requirements.

NWPG now has a strong brick-and-mortar backbone that serves as the launchpad for digital expansion.

Strategic Roadmap and Uplist Plans

NWPG has implemented an aggressive, milestone‑driven 24‑month strategic plan designed to:

Accelerate digital revenue growth.

Effectively utilize AI at the “Buyer, Seller, Operator” levels.

Consistently expand margins.

Strengthen operational efficiency.

Support an uplisting to a major national exchange.

A key pillar of our first-year strategy is Empire Rides, the NWPG proprietary reality-show platform. The goal is to transform authentic, high-engagement content into a demand-generation and conversion engine building audience loyalty, brand credibility and transaction velocity. This approach intends to convert traditional media spend into a direct revenue‑generating asset.

The NWPG NFI Empire’s hybrid model intends to bridge the traditional “onsite” and completely “offsite” worlds, delivering:

The trust and quality assurance of physical inspections and operations.

The efficiency and reach of digital marketplaces.

Improved economics for buyers and sellers.

Traditional auction houses and consignors have long dominated high‑value vehicle transactions, often imposing:

High combined fees (frequently exceeding 25%).

Non-refundable charges.

Rigid timelines.

Seller “unfriendly” terms.

At the same time purely digital platforms offer speed and reach but often lack the trust and quality control that physical oversight provides.

With the infrastructure in place, a profitable core business, and a content-driven growth engine, NWPG is exceptionally well-positioned to capture meaningful market share.

Outlook

Looking ahead, the NWPG focus is executing its roadmap with discipline and speed. NWPG is committed to building a market-leading platform that delivers superior experiences for buyers and sellers while consistently building long-term value for NWPG shareholders.

For more information on NWPG Visit: www.NewportGoldInvest.com

Email: nwpginfo@gmail.com

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the CorporateAds website

Media Contact
Company Name: Newport Gold Inc. (Stock Symbol: NWPG)
Contact Person: Justin Fried, CEO
Email: Send Email
Phone: +1 705-209-4178
Address:8 Nettleton Court
City: Collingwood
State: ON L9Y 5B9
Country: Canada
Website: www.NewportGoldInvest.com

Diabetic Nephropathy Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | AstraZeneca, NeuroBo Pharma, Don-A ST, MThera Pharma, Grünenthal, Averitas Pharma

The Key Diabetic Nephropathy Companies in the market include – Praetego, Mitsubishi Tanabe Pharma, Regenacy Pharmaceuticals, WinSanTor, Helixmith, Lexicon Pharmaceuticals, Glenmark Pharmaceuticals, Regenacy Pharmaceuticals, Pure Green, Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, and others.

The Diabetic Nephropathy market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diabetic Nephropathy pipeline products will significantly revolutionize the Diabetic Nephropathy market dynamics.

 

DelveInsight’s “Diabetic Nephropathy Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Diabetic Nephropathy, historical and forecasted epidemiology as well as the Diabetic Nephropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Diabetic Nephropathy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2022 to 2036. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

 

Get a Free sample for the Diabetic Nephropathy Market Report:

https://www.delveinsight.com/report-store/diabetic-nephropathy-market

 

Some of the key facts of the Diabetic Nephropathy Market Report:

  • The Diabetic Nephropathy market size was valued ~USD 2,800 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2022-2036)

  • In March 2026, Kodiak Sciences reported positive topline findings from the Phase III GLOW2 superiority trial evaluating ZENKUDA in patients with diabetic retinopathy. ZENKUDA is an intravitreal anti-VEGF biologic developed using Kodiak’s proprietary antibody biopolymer conjugate (ABC) platform, designed to provide sustained therapeutic activity within the eye.

  • According to REGENXBIO’s Q4 2025 financial and operational update, the company, in partnership with AbbVie, expects to release topline results from the pivotal ATMOSPHERE and ASCENT trials evaluating sura-vec delivered via the subretinal route in Q4 2026. Pending successful outcomes, global regulatory filings are planned for 2027.

  • According to CDC data, the prevalence of diabetic retinopathy in the US rises with age, affecting 13% of individuals under 25 and increasing to 28.4% among those aged 65–79.

  • Based on secondary analysis, among adults aged 40 and above, approximately 8.94 million are affected by diabetic retinopathy, with 1.71 million experiencing vision-threatening complications. These statistics highlight the urgent need for age-specific screening programs and early intervention strategies.

  • Diabetic retinopathy affects approximately 3%–4.1% of the European population, underscoring its significant impact on public health. Prevalence of diabetic retinopathy in those over age 60 is highest in France, followed by Germany. This prevalence highlights the growing burden of diabetes-related complications in the region, emphasizing the need for widespread screening, early detection, and proactive management to mitigate vision loss among affected individuals.

  • According to secondary analysis, at any given point, 15–30% of the diabetic population suffers from some form of diabetic retinopathy. Approximately half of the patients are unaware of their condition due to a lack of symptoms and mild non-proliferative disease that might go undetected. Although diabetic retinopathy, through diabetic macular edema and proliferative diabetic retinopathy, is the leading cause of vision loss among working-age populations in the US and many other countries, much of the causative ophthalmic pathology is treatable.

  • According to the American Association of Ophthalmology, non-proliferative diabetic retinopathy is notably prevalent across Europe, with the UK exhibiting the highest rate at 48%, followed by Spain at 38.9%, while Germany reports a significantly lower prevalence of 10%. These variations highlight regional disparities, emphasizing the need for tailored preventive strategies and healthcare interventions to address diabetic eye complications effectively.

  • Based on secondary research, diabetic retinopathy affects around 3 million individuals in Japan, ranking as the third leading cause of visual impairment. This substantial prevalence underscores the growing impact of diabetes-related eye diseases, highlighting the need for improved screening, early intervention, and comprehensive management strategies to reduce vision loss among affected populations.

  • Key Diabetic Nephropathy Companies: Praetego, Mitsubishi Tanabe Pharma, Regenacy Pharmaceuticals, WinSanTor, Helixmith, Lexicon Pharmaceuticals, Glenmark Pharmaceuticals, Regenacy Pharmaceuticals, Pure Green, Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, and others

  • Key Diabetic Nephropathy Therapies: PTG-630, MT-8554, Ricolinostat, WST 057, Engensis, VM202, LX9211, GRC 17536, Ricolinostat, CBD, VX-548, LY3857210, and others

  • The Diabetic Nephropathy epidemiology based on gender analyzed that the prevalence of Diabetic Nephropathy increases significantly with age

 

Diabetic Nephropathy Overview

Diabetic nephropathy is a serious kidney-related complication of diabetes, characterized by damage to the blood vessels in the kidneys due to prolonged high blood sugar levels. This condition leads to a gradual decline in kidney function and can result in end-stage renal disease (ESRD) if not managed properly. Early signs of diabetic nephropathy include the presence of protein in the urine (albuminuria) and elevated blood pressure. Risk factors for developing this condition include poor glycemic control, hypertension, and a family history of kidney disease. Management focuses on controlling blood sugar and blood pressure levels, as well as lifestyle changes and medications to slow the progression of kidney damage.

 

To Know in detail about the Diabetic Nephropathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diabetic Nephropathy Market Insights

 

Diabetic Nephropathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Diabetic Nephropathy Epidemiology Segmentation:

The Diabetic Nephropathy market report proffers epidemiological analysis for the study period 2022–2036 in the 7MM segmented into:

  • Total Prevalent Cases of Diabetic Retinopathy

  • Gender-specific Prevalent Cases of Diabetic Retinopathy

  • Type-specific Prevalent Cases of Diabetic Retinopathy

  • Age-specific Prevalent Cases of Diabetic Retinopathy

  • Total-treated Cases of Diabetic Retinopathy

 

Download the report to understand which factors are driving Diabetic Nephropathy epidemiology trends @ Diabetic Nephropathy Epidemiological Insights

 

Diabetic Nephropathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Nephropathy market or expected to get launched during the study period. The analysis covers Diabetic Nephropathy market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Diabetic Nephropathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Diabetic Nephropathy Therapies and Key Companies

  • Ranibizumab (LUCENTIS): Genentech

  • Aflibercept (EYLEA): Ionis Pharmaceuticals and AstraZeneca

  • Tarcocimab tedromer (KSI-301): Kodiak Sciences

  • ABBV-RGX-314: Regenxbio/AbbVie

  • PTG-630: Praetego

  • MT-8554: Mitsubishi Tanabe Pharma

  • Ricolinostat: Regenacy Pharmaceuticals

  • WST 057: WinSanTor

  • Engensis: Helixmith

  • VM202: Helixmith

  • LX9211: Lexicon Pharmaceuticals

  • GRC 17536: Glenmark Pharmaceuticals

  • Ricolinostat: Regenacy Pharmaceuticals

  • CBD: Pure Green

  • VX-548: Vertex Pharmaceuticals Incorporated

  • LY3857210: Eli Lilly and Company

 

To know more about Diabetic Nephropathy treatment, visit @ Diabetic Nephropathy Medications

 

Diabetic Nephropathy Market Drivers

  • Rising Diabetes Prevalence: The growing global burden of type 1 and type 2 diabetes is increasing the number of patients at risk of developing diabetic nephropathy.

  • Increasing Awareness and Early Diagnosis: Improved screening programs and greater awareness of diabetic kidney disease are leading to earlier detection and treatment.

  • Advancements in Therapeutics: The introduction of novel therapies, including SGLT2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists, and emerging pipeline candidates, is driving market growth.

  • Growing Healthcare Expenditure: Increased investments in chronic disease management and kidney care are supporting market expansion.

 

Diabetic Nephropathy Market Barriers

  • High Treatment Costs: Advanced therapies and long-term disease management can impose a significant financial burden on patients and healthcare systems.

  • Limited Disease Reversibility: Current treatments primarily slow disease progression rather than cure the condition, limiting therapeutic outcomes.

  • Underdiagnosis in Early Stages: Many patients remain undiagnosed until the disease has significantly progressed, affecting treatment effectiveness.

  • Adverse Effects and Safety Concerns: Some therapies may be associated with side effects that impact patient adherence and treatment adoption.

 

Scope of the Diabetic Nephropathy Market Report

  • Study Period: 2022–2036

  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

  • Key Diabetic Nephropathy Companies: Praetego, Mitsubishi Tanabe Pharma, Regenacy Pharmaceuticals, WinSanTor, Helixmith, Lexicon Pharmaceuticals, Glenmark Pharmaceuticals, Regenacy Pharmaceuticals, Pure Green, Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, and others

  • Key Diabetic Nephropathy Therapies: PTG-630, MT-8554, Ricolinostat, WST 057, Engensis, VM202, LX9211, GRC 17536, Ricolinostat, CBD, VX-548, LY3857210, and others

  • Diabetic Nephropathy Therapeutic Assessment: Diabetic Nephropathy current marketed and Diabetic Nephropathy emerging therapies

  • Diabetic Nephropathy Market Dynamics: Diabetic Nephropathy market drivers and Diabetic Nephropathy market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Diabetic Nephropathy Unmet Needs, KOL’s views, Analyst’s views, Diabetic Nephropathy Market Access and Reimbursement

 

Discover more about therapies set to grab major Diabetic Nephropathy market share @ Diabetic Nephropathy Treatment Landscape

 

Table of Contents

1. Diabetic Nephropathy Market Report Introduction

2. Executive Summary for Diabetic Nephropathy

3. SWOT analysis of Diabetic Nephropathy

4. Diabetic Nephropathy Patient Share (%) Overview at a Glance

5. Diabetic Nephropathy Market Overview at a Glance

6. Diabetic Nephropathy Disease Background and Overview

7. Diabetic Nephropathy Epidemiology and Patient Population

8. Country-Specific Patient Population of Diabetic Nephropathy

9. Diabetic Nephropathy Current Treatment and Medical Practices

10. Diabetic Nephropathy Unmet Needs

11. Diabetic Nephropathy Emerging Therapies

12. Diabetic Nephropathy Market Outlook

13. Country-Wise Diabetic Nephropathy Market Analysis (2022–2036)

14. Diabetic Nephropathy Market Access and Reimbursement of Therapies

15. Diabetic Nephropathy Market Drivers

16. Diabetic Nephropathy Market Barriers

17. Diabetic Nephropathy Appendix

18. Diabetic Nephropathy Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679 Source: https://www.delveinsight.com/report-store.php
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Diabetic Nephropathy Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | AstraZeneca, NeuroBo Pharma, Don-A ST, MThera Pharma, Grünenthal, Averitas Pharma

Artic Advertising & Media Highlights Uncommitted 6’3” WR CJ Favors Jr. After Van Hook Training Block

Artic Advertising & Media Highlights Uncommitted 6’3” WR CJ Favors Jr. After Van Hook Training Block

CJ Favors Jr., an uncommitted 6’3”, 215-pound wide receiver with a 6’7” wingspan, is drawing attention as a late-cycle 2026 prospect after producing 18.7 yards per catch and completing a five-month training block at Van Hook Sports Performance
Favors brings a 6’7” wingspan, 42-inch vertical, 18.7 yards per catch, and two years of eligibility as programs continue evaluating late-cycle receiver talent

Artic Advertising & Media is highlighting the recruiting profile of CJ Favors Jr., an uncommitted 6-foot-3, 215-pound wide receiver with a 6-foot-7 wingspan who has spent the past five months training full-time at Van Hook Sports Performance in Henderson, Nevada, while preparing for the right college football opportunity ahead of the 2026 season.

Favors, who previously competed at St. Scholastica, brings the size, production, athletic profile, and upside that college programs continue to evaluate in late-cycle receiver talent. Along with his frame and length, he has recorded a 42-inch vertical and a reported 4.48-second 40-yard dash from a wide receiver stance.

During the 2025 season — his first year starting at wide receiver at the college level — Favors recorded 34 receptions for 634 yards, averaging 18.7 yards per catch, with five touchdowns and zero fumbles. Competing in a run-heavy offensive system, he maximized limited opportunities while showing the ability to stretch the field, win contested catches, protect the football, and create explosive plays.

Favors has also drawn attention from scouting circles. Oliver James West, Midwest Scouting Director for Prep Redzone, described Favors as having “ridiculous length,” “lean, ropey muscular definition,” “great speed,” and “explosive” traits after watching him compete at the University of Minnesota prospect camp.

“Really like his athletic upside and dynamic ability,” West said.

Since January, Favors has trained at Van Hook Sports Performance, a Las Vegas-area facility known for attracting elite talent, including NFL and MLB athletes preparing for their seasons. The professional training environment has helped Favors continue sharpening his route running, explosiveness, strength, conditioning, release package, football IQ, physicality, and overall consistency.

“I know I’m not the biggest name available right now, but I believe I’m one of the best opportunities still on the board,” said CJ Favors Jr. “At 6’3” with a 6’7” wingspan, I can win matchups, stretch the field, and give a quarterback a target who can go get the football. I’ve been training like a pro, preparing for the right program to give me a real shot.”

Coach Brian Van Hook, Founder and Head Performance Coach of Van Hook Sports Performance, believes Favors has the tools to impact a program.

“CJ is something special,” said Coach Brian Van Hook. “He has the ‘it’ factor. His size, length, athleticism, work ethic, and mindset give him a chance to change the outlook of a team.”

Favors’ recruitment has begun gaining momentum, with multiple college programs reaching out and offers currently under consideration. Among the programs showing serious interest is an HBCU program viewed as a potential national contender in the race toward the Cricket Celebration Bowl, further signaling that college staffs are taking notice of his size, production, leadership, and upside.

Favors currently holds a 3.0 GPA, plans to major in Psychology, and has two years of eligibility remaining. He remains open in the recruiting process while continuing conversations with programs seeking immediate receiver talent at the D1 and D2 levels.

Highlight Film: https://x.com/showtimecj12/status/1999898941115023401?s=46

Additional Highlights: https://www.tiktok.com/@c.favvv?_r=1&_t=ZT-96jN1XgbEFS

YouTube Shorts: https://www.youtube.com/@C.Favvvv/shorts

Van Hook Sports Performance: https://vanhooktraining.com/

Player Information

Name: CJ Favors Jr. | Position: Wide Receiver | Height/Weight: 6’3” / 215 lbs | Wingspan: 6’7” | Vertical: 42 inches | 40-Yard Dash: 4.48 seconds from WR stance | 2025 Stats: 34 receptions, 634 yards, 18.7 YPC, 5 TDs, 0 fumbles | Status: Uncommitted / Available for 2026 Season

About Artic Advertising & Media

Artic Advertising & Media is a media, marketing, and promotional agency that helps athletes, businesses, and brands increase visibility through strategic storytelling, digital promotion, media outreach, and campaign development. Website: https://articadvertisingcorp.com

Recruiting Contact

CJ Favors Jr. Phone: 612-840-7899 Email: cjfavorsjr@gmail.com

Media Contact
Company Name: Artic Advertising & Media
Contact Person: Leroy Brice
Email: Send Email
Phone: 702-418-3320
City: LAS VEGAS
State: NV
Country: United States
Website: https://articadvertisingcorp.com/